SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-20-040501
Filing Date
2020-03-30
Accepted
2020-03-30 17:03:57
Documents
4
Period of Report
2020-04-23

Document Format Files

Seq Description Document Type Size
1 FORM 14A tm2014157-1_pre14a.htm PRE 14A 361091
2 GRAPHIC lg_anchiano.jpg GRAPHIC 211754
3 GRAPHIC tm2014157d1-pc_meeting1.jpg GRAPHIC 523363
4 GRAPHIC tm2014157d1-pc_meeting2.jpg GRAPHIC 364423
  Complete submission text file 0001104659-20-040501.txt   1866266
Mailing Address 5 KIRYAT HAMADA ST PO BOX 45032 JERUSALEM L3 9777401
Business Address 5 KIRYAT HAMADA ST PO BOX 45032 JERUSALEM L3 9777401 972-2-5486555
Anchiano Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38807 | Film No.: 20758042
SIC: 2834 Pharmaceutical Preparations